Furthermore, a functional variant in the NKX3.1 gene was associated with the increased risk of prostate cancer in subjects from the Selenium and Vitamin E Cancer Prevention Trial (SELECT)35. This evidence concerns the gene NKX3-1 and Familial prostate cancer.